226330 — Syntekabio Share News
0.000.00%
Last trade - 00:00- KR₩26bn
- KR₩25bn
- KR₩3bn
Brief: Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel
Brief: Syntekabio Wins 397 Million Won Order
Brief: Syntekabio To Conduct Capital Increase Of 32 Billion Won
Brief: Metavia Announces Ai-Driven Collaboration With Syntekabio To Explore Additional Indications For Da-1241